Tuesday, September 27, 2022
News

Corbevax approved as heterologous vaccine for precaution dose: Centre

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | Thursday, 2022 4:45:09 AM IST
The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin.

In a letter to states, Union Health Secretary Rajesh Bhushan said: "Corbevax will be available as precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for population above 18 years."

This enables use of Corbevax as a heterologous Covid-19 vaccine for precaution dose administration in this age group, he said.

The Centre, in the letter, also informed the states that there will be no change in existing guidelines for homologous precaution dose administration of Covaxin and Covishield vaccine.

"In addition to the existing homologous precaution dose, the option of a heterologous precaution dose with Corbevax would be available to all persons above 18 years of age," Bhushan said in the letter.

"All necessary changes in regard to the administration of heterologous precaution dose using Corbevax, to those who are eligible and due for precaution dose have been made on the Co-WIN portal. This provision would be live from 12th August (Friday), 2022," he said in the letter.

Meanwhile, Union Health Minister Mansukh Mandaviya also tweeted, "Further Strengthening India's arsenal against COVID-19. @MoHFW_India approves Corbevax as #PrecautionDose for those above 18 yrs vaccinated with either Covishield or Covaxin, 6 months or 26 weeks after administration of 2nd dose. This provision would be live from 12th August".

--IANS avr/vd

( 265 Words)

2022-08-10-22:36:01 (IANS)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Lassa virus endemic area could significa...
Study: New technologies can be key to pr...
Protein supplement helps control Type 2 ...
Study reveals that babies react to taste...
IIT-Guwahati researchers develop new str...
Best performing states awarded on Day 2 ...
More...
 
INDIA WORLD ASIA
SC will live stream Constitution bench p...
Delhi HC refuses to stay 1986 batch IPS ...
MP police arrests woman in Noida for dup...
Nitish Kumar returns after meeting with ...
'Will submerge separation of power': SC ...
Jammu admin appeals citizens to update A...
More...    
 
 Top Stories
Manigam seer, a hamlet in Anantnag ... 
Ayushmann Khurrana's 'Doctor G' new... 
Mumbai: Dawood Ibrahim's alleged ai... 
IAF's Surya Kiran Aerobatic Display... 
Study finds how ancient viral genes... 
Assam: PFI member arrested, claim p... 
Lassa virus endemic area could sign... 
Media as we know is constantly frag...